No Detail Found!

Ways to manage Hepatitis C without cirrhosis: Treatment by comparison of coded eastern medicine Hepcinal with Interferon alpha 2b and Ribavirin.

Author(s)
Allah Nawaz Department of Basic Clinical Sciences, Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan
Halima Nazar Department of Basic Clinical Sciences, Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan
Khan Usmanghani Department of Basic Clinical Sciences, Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan
Zeeshan Ahmed Sheikh Department of Basic Clinical Sciences, Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan; Research and Development Department, Herbion Pakistan Private Limited, Karachi, Pakistan
Muhammad Amjad Chishti Department of Basic Clinical Sciences, Faculty of Eastern Medicine, Hamdard University, Karachi, Pakistan
Irshad Ahmad Department of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan
Abstract
Hepatitis C virus (HCV) infection is a serious and significant global health problem in the Pakistan and elsewhere. In majority of cases HCV infection remains asymptomatic but in advance cases it may progress to fibrosis of liver, shrinkage of liver cells or failure of liver. The hepatitis C may progress to cause liver cirrhosis that mostly develop in 20% of the affected patients in 20 years with an increased risk in male, alcoholic drink, immune-compromised and who acquire HCV infection after the age of 40 years. This was an open-label prospective study conducted on 66 clinically and immunologically diagnosed cases of HCV infection. In Hepcinal treated group, there were significant improvement in HCV associated symptoms compared to control group (p
Publication Details
Page(s) 919-927
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 29, Issue: 3, Year: 2016

Request the full text from PASTIC

0

Citations

0

Downloads

200

Views